Elaine Y Hsiao

This inventor holds 14 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: California Institute of Technology, University of California. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Y Hsiao. Retrieved from https://idiyas.com/inventor/elaine-y-hsiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Pasadena, CA (US) (2022 - 2023)
Rowland Heights, CA (US) (2016 - 2024)
Los Angeles, CA (US) (2021 - 2024)

Company Filing History:

8 out of 4,629

California Institute of Technology

patents

8 out of 16,035

University of California

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514883 - COMPOSITIONS AND METHODS FOR MODULATING LIPID AND STEROID METABOLISM (2026-01-06),

2. 12491217 - Compositions and methods for promoting healthy neural development in an unborn baby (2025-12-09),

3. 12364717 - Compositions and methods for inhibiting seizures (2025-07-22),

4. 12292445 - Methods of selecting subjects for treatment with metabolomic modulators (2025-05-06),

5. 12128075 - Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders (2024-10-29),

6. 11896629 - Probiotic therapies for treating Rett syndrome (2024-02-13),

7. 11883441 - Compositions and methods for inhibiting seizures (2024-01-30),

8. 11744867 - Modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate in behavior and disease (2023-09-05),

9. 11224624 - Modulation of microbial synthesis of 4-etylphenol and 4-ethylphenyl sulfate in behavior and disease (2022-01-18),

10. 11129858 - Compositions and methods for inhibiting seizures (2021-09-28),

11. 11052151 - Diagnosis and treatment of autism spectrum disorder (2021-07-06),

12. 10220089 - Diagnosis and treatment of autism spectrum disorder (2019-03-05),

13. 10124025 - Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders (2018-11-13),

14. 9452189 - Probiotic therapies for autism (2016-09-27),

Title: Elaine Y Hsiao: Innovator in Seizure Treatment

Introduction

Elaine Y Hsiao is a prominent inventor based in Pasadena, CA, known for her significant contributions to the field of neuroscience and seizure treatment. With a total of 14 patents, she has made remarkable strides in developing methods and compositions aimed at treating and preventing seizures.

Latest Patents

Among her latest patents, Hsiao has developed compositions and methods for inhibiting seizures. These innovations include methods of treating or preventing seizures in subjects by administering compositions that comprise specific bacteria. Additionally, she has created methods for selecting subjects with seizure disorders for treatment, which also involve determining the efficacy of the treatment and adjusting dosage and frequency. These advancements highlight her commitment to improving the lives of those affected by seizure disorders.

Career Highlights

Hsiao has worked at prestigious institutions such as the California Institute of Technology and the University of California. Her work at these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Hsiao has collaborated with notable colleagues, including Sarkis K Mazmanian and Paul H Patterson. These partnerships have further enhanced her research and innovation in the field of neuroscience.

Conclusion

Elaine Y Hsiao's contributions to the treatment of seizures through her innovative patents and collaborations underscore her role as a leading inventor in her field. Her work continues to pave the way for advancements in neuroscience and patient care.

Profile summary based on public USPTO records.